Interpretable Machine Learning
Interpretable Machine Learning
Georgios Exarchakis
The University of Bath invites applications for a fully-funded PhD position in Machine Learning, as part of the prestigious URSA competition. This project focuses on developing interpretable machine learning methods for high-dimensional data, with an emphasis on recognizing symmetries and incorporating them into efficient, flexible algorithms. This PhD position offers the opportunity to work within a leading research environment, using state-of-the-art tools such as TensorFlow, PyTorch, and Scikit-Learn. The research outcomes have potential applications in diverse fields, and students are encouraged to bring creative and interdisciplinary approaches to problem-solving.
Robotic mapping and generative modelling of cytokine response
We have developed a robotic platform allowing us to monitor cytokines dynamics (including IL-2, IFN-g, TNF, IL-6) of immune cells in vitro, with unprecedented resolution. To understand the complex emerging dynamics, we use interpretable machine learning techniques to build a generative model of cytokine response. We discover that, surprisingly, immune activity is encoded into one global parameter, encoding ligand antigenic properties and to a less extent ligand quantity. Based on this we build a simple interpretable model which can fully explain the broad variability of cytokines dynamics. We validate our approach using different lines of cells and different ligands. Two processes are identified, connected to timing and intensity of cytokine response, which we successfully modulate using drugs or by changing conditions such as initial T cell numbers. Our work reveals a simple "cytokine code", which can be used to better understand immune response in different contexts including immunotherapy. More generally, it reveals how robotic platforms and machine learning can be leveraged to build and validate systems biology models.
Enhancing hypothesis testing via interpretable machine learning frameworks
FENS Forum 2024